Balanced news tone
News Sentiment
COCP sentiment intelligence
Cocrystal Pharma Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
55
Balanced news tone
51 relevant articles
News tone and price action are not far from neutral.
82/100 classification confidence.
directly relevant articles
high-authority source matches
-2.9% over one week, +1.5% over four weeks, trend inactive, and below fair value.
What's Driving the Micro-Cap Mania in SKYQ and COCP
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
82/100 classification
One-week reaction
-2.9%
Price reacting lower
Trend fit
Trend inactive
1.5% over four weeks
Fair value
-38.8%
Below fair value
Value support
Sentiment Mix
Positive, neutral, negative
Positive
12
Neutral
35
Negative
4
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
Zacks Small Cap Research
Direct company coverage
COCP: Presentation Highlights CDI-988
Cocrystal Pharma (NASDAQ: COCP) presented encouraging data for its antiviral drug CDI-988 for norovirus infection at the ICAR 2026 conference. The presentation highlighted CDI-988's novel mechanism of action, broad-spectrum coverage, promising pharmacokinetic/pharmacodynamic data
- Tone
- Positive 73/100
- Event
- Market update
- Published
- 01 Jun 2026 16:40
- Source
- Zacks Small Cap Research
Moomoo
Direct company coverage
Noble Financial Maintains Cocrystal Pharma(COCP.US) With Buy Rating, Raises Target Price to $10
Noble Financial has reiterated its Buy rating for Cocrystal Pharma (COCP.US) and increased the target price to $10. This signals a continued positive outlook from the firm regarding Cocrystal Pharma's stock performance and potential.
- Tone
- Positive 92/100
- Event
- Analyst action
- Published
- 28 May 2026 00:39
- Source
- Moomoo
GlobeNewswire
Direct company coverage
Cocrystal Pharma Announces Discovery of Pan-Viral Inhibitors Targeting Hantavirus, Bunyavirus and Influenza
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 May 2026 07:00
- Source
- GlobeNewswire
GlobeNewswire
Direct company coverage
Cocrystal Pharma Provides Business Update and Reports First Quarter 2026 Financial Results
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 15 May 2026 12:00
- Source
- GlobeNewswire
simplywall.st
Industry context
There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 15 May 2026 07:00
- Source
- simplywall.st
Market source
Industry context
Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 May 2026 07:00
- Source
- Market source
simplywall.st
Industry context
Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- simplywall.st
Market source
Industry context
Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- Market source
GlobeNewswire
Direct company coverage
Cocrystal Pharma Presentation at ICAR 2026 Highlights Mechanism of Action and Clinical Advancement of CDI-988 for the Prevention and Treatment of Norovirus Infection
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Apr 2026 20:05
- Source
- GlobeNewswire
Market source
Industry context
Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Apr 2026 07:00
- Source
- Market source
Market source
Industry context
Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 Apr 2026 07:00
- Source
- Market source
simplywall.st
Direct company coverage
We're Keeping An Eye On Cocrystal Pharma's (NASDAQ:COCP) Cash Burn Rate
- Tone
- Neutral 50/100
- Event
- Balance sheet
- Published
- 04 Apr 2026 07:00
- Source
- simplywall.st
Stock Titan
Direct company coverage
Cocrystal's norovirus pill gets FDA fast track amid 685M yearly cases
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Apr 2026 07:00
- Source
- Stock Titan
GlobeNewswire
Direct company coverage
Cocrystal Pharma Receives FDA Fast Track Designation for CDI-988 for Norovirus Infection Treatment and Preventive
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Apr 2026 07:00
- Source
- GlobeNewswire
Stocktwits
Direct company coverage
COCP Stock Soars 75% — What Is The Link To Cocrystal’s Norovirus Treatment?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Apr 2026 07:00
- Source
- Stocktwits
StocksToTrade
Direct company coverage
Cocrystal Pharma Advances in Norovirus Study as Financial Challenges Loom
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Apr 2026 07:00
- Source
- StocksToTrade
timothysykes.com
Direct company coverage
Cocrystal Pharma Advances Antiviral Trials Amid Financial Strategy Shift
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Apr 2026 07:00
- Source
- timothysykes.com
TradingView
Industry context
A Look Back at Biotechnology Stocks’ Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 29 Mar 2026 07:00
- Source
- TradingView
MSN
Direct company coverage
Cocrystal Pharma files to sell 5.74M shares of common stock for holders
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 19 Sep 2025 20:59
- Source
- MSN
Stock Titan
Direct company coverage
Cocrystal Pharma (COCP) Stock Price, News & Analysis
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 Apr 2025 01:20
- Source
- Stock Titan
Stock Titan
Direct company coverage
Cocrystal Pharma (COCP) Stock News & Updates
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Aug 2020 01:57
- Source
- Stock Titan